S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ACER Acer Therapeutics Inc

0.90

0.00 (0.00%)

After Hours

Last Updated: 19:00:00

Delayed by 15 minutes

Acer Therapeutics down 10% on share offering

To read the full story on Seeking Alpha, click here.

Acer Therapeutics (NASDAQ:ACER)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Acer Therapeutics Charts.

Acer Therapeutics (NASDAQ:ACER)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Acer Therapeutics Charts.

Acer Therapeutics Inc News

Form 425 - Prospectuses and communications, business combinations
Wednesday 8 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 November 2023 (6 months ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 2 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 2 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 2 November 2023 (6 months ago) • Edgar (US Regulatory)

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Acer Therapeutics Shareholders Vote "FOR" the Proposed Merger and Related Proposals
Thursday 2 November 2023 (6 months ago) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 30 October 2023 (6 months ago) • Edgar (US Regulatory)

Form DEFM14A - Definitive proxy statement relating to merger or acquisition
Tuesday 10 October 2023 (7 months ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 31 August 2023 (8 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 31 August 2023 (8 months ago) • Edgar (US Regulatory)

Zevra Therapeutics to Acquire Acer Therapeutics, Expanding its Rare Disease Portfolio and Adding Commercial Product
Thursday 31 August 2023 (8 months ago) • GlobeNewswire Inc.

Acer Therapeutics Reacquires Worldwide Development, Commercialization and Economic Rights to OLPRUVA™ from Relief Therapeutics, Excluding the Geographical Europe
Wednesday 30 August 2023 (8 months ago) • GlobeNewswire Inc.

More Acer Therapeutics Inc News Articles

Global Developments (PK)

Mullen Automotive

NaturalShrimp (QB)

FBEC Worldwide (PK)

Tonner One World (PK)

Wanderport (PK)

Branded Legacy (PK)

Moon Equity (PK)

Virexit Technologies (PK)

NioCorp Developments

BlueFire Equipment (PK)

Impact Fusion (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions